32
Participants
Start Date
December 27, 2021
Primary Completion Date
June 1, 2028
Study Completion Date
June 1, 2030
Standard of Care
Participants will be randomly assigned and receive standard of care as determined by their physician and may include: palliative radiation and/or a systemic therapy (like chemotherapy, immunotherapy, or targeted therapies).
SBRT
SBRT to 1-5 sites of metastatic disease over the course of 1-8 business days to each area of cancer
RECRUITING
University of Chicago, Chicago
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
Adenoid Cystic Carcinoma Research Foundation
OTHER
Gateway for Cancer Research
OTHER
Dana-Farber Cancer Institute
OTHER